Deventure Drugs Private Limited

Deventure Drugs Private Limited - pharma in New Delhi, Delhi, India. FY 2026 financials & compliance.
CIN U24304DL2020PTC363445 Incorporated 25 April 2020 ROC Delhi HQ New Delhi, Delhi, India
Active Private Limited Company pharma
Revenue · FY 2024
₹691
Latest filing
Authorised capital
₹10 Lakh
Registered with MCA
Paid-up capital
₹1 Lakh
Issued & subscribed
Company age
6 yrs
Est. 2020
Directors on board
2
As per MCA filings
Last financials
Mar 2024
Balance sheet date
Last AGM
30 Sep 2024
Annual general meeting
Company status
Active
MCA master data

About Deventure Drugs Private Limited

Data last updated:

Deventure Drugs Private Limited is a private limited company based in New Delhi, Delhi, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 25 April 2020 and has been in existence for over 6 years.

The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U24304DL2020PTC363445.

The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Rohit Mukul and Verinder Chhabra.

Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at 913 D – Mall Netaji Subhash Place Pitampura, New Delhi, Delhi, India – 110034.

For more details, the company can be reached via its website zeelab.co.in.

Company details

CIN U24304DL2020PTC363445
Registration Number 363445
Incorporation Date 25 April 2020
ROC Delhi
Listing Status Unlisted
Company Status Active

Contact details

Deventure Drugs Private Limited's registered office is in New Delhi, Delhi. Its e-mail address is in the company report.

  • Email
  • Social Media
  • Registered Address
    913 D – Mall Netaji Subhash Place Pitampura, New Delhi, Delhi, India – 110034
  • Industry
    Pharma, Drug Formulation & Development

To see the full contact details of Deventure Drugs Private Limited, buy the company report.

Comprehensive company report
Deventure Drugs Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Financials of Deventure Drugs Private Limited

FY 2024 filings available

Deventure Drugs Private Limited reported revenue of ₹691 for FY 2024.

Revenue · FY 2024
₹691

Financial Statement Summary

MetricsFY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profit and Loss Statement
Revenue from Operations
Other Income
Total Revenue
Cost of Materials Consumed
Employee Benefit Expense
Finance Costs
Depreciation and Amortisation
Other Expenses
Total Expenses
EBITDA
Profit Before Tax
Tax Expense
Net Profit (PAT)
Balance Sheet
Share Capital
Reserves and Surplus
Net Worth (Total Equity)
Long-term Borrowings
Short-term Borrowings
Trade Payables
Total Liabilities
Fixed Assets
Investments
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

MetricsFY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profitability
EBITDA Margin
Net Profit Margin
Return on Equity (ROE)
Return on Capital Employed (ROCE)
Return on Assets (ROA)
Liquidity and Debt
Current Ratio
Quick Ratio
Debt-to-Equity Ratio
Interest Coverage Ratio
Efficiency and Growth
Asset Turnover
Receivable Days
Payable Days
Inventory Days
Revenue Growth
Net Profit Growth

To see the full financial statements and ratios of Deventure Drugs Private Limited, buy the company report.

Board of directors of Deventure Drugs Private Limited

Deventure Drugs has 2 directors on record. No former directors are listed.

Current Directors
NameDesignationAppointment DateTenureStatus
Rohit MukulDirector25 Apr 20206 Years 6 MonthsCurrent
Verinder ChhabraDirector25 Apr 20206 Years 6 MonthsCurrent

Auditor

Deventure Drugs Private Limited is audited by TAGEJA R & CO for the financial year 2022.

Auditor firmFinancial yearFirm registration number
TAGEJA R & COFY 2022036385N

Shareholding

The shareholding of Deventure Drugs Private Limited is on record for 2 financial years, the latest being FY 2022, split between promoters, domestic institutions, public shareholders and others.

Shareholder categoryFY 2022FY 2021
Promoters
Domestic institutional investors (DII)
Public
Others

To see the full shareholding pattern of Deventure Drugs Private Limited, buy the company report.

MSME payment delays

No delayed payments to MSME suppliers are on our record for Deventure Drugs Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.

Employees & EPFO

Deventure Drugs Private Limited has 1 active EPFO establishment as of Nov 12, 2026.

Active EPFO establishments
1

GST

No GST registration is on our record for Deventure Drugs Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.

Recent activity

Deventure Drugs Private Limited has 2 board changes on record since 2020: 2 appointments. The latest: Rohit Mukul was appointed as Director on 25 Apr 2020.

AGM
Deventure Drugs Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records.
Filing
Deventure Drugs Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Delhi I.
Appointed
Rohit Mukul was appointed as Director.
Appointed
Verinder Chhabra was appointed as Director.
Incorporation
25 Apr 2020
Deventure Drugs Private Limited was registered on 25 Apr 2020 with Roc Delhi I & aged 6 years 6 months as per MCA records.

Frequently asked questions

Deventure Drugs is an active private limited company based in New Delhi, Delhi, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 25 April 2020 (6+ years old) and is registered under CIN U24304DL2020PTC363445.

Deventure Drugs has 2 current directors:

The latest financial statements of Deventure Drugs on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 30 September 2024. Year-wise statements from FY 2021 are in the company report.

The CIN (Corporate Identification Number) of Deventure Drugs is U24304DL2020PTC363445. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Deventure Drugs was incorporated on 25 April 2020, making it 6+ years old. It is registered with the Registrar of Companies, Delhi.

Rohit Mukul was appointed as Director on 25 Apr 2020. Verinder Chhabra was appointed as Director on 25 Apr 2020.

Deventure Drugs can be reached through the website zeelab.co.in. Its registered office is in New Delhi, Delhi, India.

The registered office of Deventure Drugs is at 913 D – Mall Netaji Subhash Place Pitampura, New Delhi, Delhi, India – 110034.

Deventure Drugs operates in the pharma industry, in the drug formulation and development segment.

Deventure Drugs is registered under the jurisdiction of the Registrar of Companies (ROC), Delhi.